YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Fresenius Medical Care AG & Co. FMS entered 2026 with improving profitability, accelerating execution of its transformation strategy and growing momentum in HighVolumeHDF and value-based care. However, persistent treatment volume weakness,…
BAD HOMBURG, Germany, Oct. 7, 2026 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, today announced that Shervin J. Korangy (51) will become Chief Exec…
European equities traded in the US as American depositary receipts were lower on Tuesday morning, de PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Fresenius Medical Care AG & Co. FMS recently refined its China commercial strategy to focus on areas offering stronger long-term growth potential and strengthen its position in the country's dialysis market. The company plans to prioritize…
Refinements support the Company's China go-to-market and commercial strategy in an important and growing market Strategy focuses on localized portfolio and innovation in China Portfolio decisions expected to result in related one-time cost…
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. The U.S. Food and Drug Administration (FDA) on Tuesday issued a warning letter to Fresenius Medical Care AG & Co. KGaA's Fresenius USA Man…
Fresenius Medical Care AG FMS is accelerating the U.S. rollout of its 5008X CAREsystem as it pushes high-volume hemodiafiltration, or HVHDF, into more clinics. The deployment adds a technology-led growth avenue across both services and pro…
Fresenius Medical Care AG & Co. FMS entered 2026 with improving profitability, accelerating execution of its transformation strategy and growing momentum in HighVolumeHDF and value-based care. However, persistent treatment volume weakness,…
Publication in the Journal of the American Society of Nephrology reports that, in a large multinational real-world evidence study using a target trial emulation design, hemodiafiltration (HDF) was associated with a 28% lower relative risk…
Fresenius Medical Care AG FMS reported second-quarter 2026 adjusted earnings per share (EPS) of 66 cents, which increased 28% year over year at constant currency (cc), supported by stronger Care Delivery profitability and share repurchases…
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Fresenius Medical Care is expanding its BEACON-US clinical initiative to build real-world evidenc…
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Fresenius Medical Care stock has recovered modestly in the short term yet is still down about 30% over the past five years, while r…
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Fresenius Medical Care (XTRA:FME) has drawn fresh attention after the Supervisory Board appointed…
Earnings Call Insights: Fresenius Medical Care (FMS) Q2 2026 MANAGEMENT VIEW * "We continued our strong start to the year, delivering another quarter of highly profitable growth" (Chair of Management Board & CEO Helen Giza). She said opera…
This article first appeared on GuruFocus. Revenue: Solid organic group revenue growth of 5% in Q2, with a 4% increase at constant currency. Operating Income: Increased significantly by 23% at constant currency, with growth accelerating and…
BAD HOMBURG, Germany, Aug. 3, 2026 /PRNewswire/ -- The Supervisory Board of Fresenius Medical Care AG, the world's leading provider of products and services for individuals with renal disease, has appointed Cassie McLean (48) as a member o…
Organic revenue growth1 of 5% with growth in all operating segments Operating income2 grew by 23%, resulting in further margin expansion to 11.7% Reported operating income grew by 10% and reported net income3 decreased by 3% Earnings per s…
BEACON-US research initiative is evaluating the clinical outcomes and patient experiences of high-volume hemodiafiltration in routine U.S. clinical practice across diverse patient populations Fresenius Medical Care expands access to the th…
This article first appeared on GuruFocus. Release Date: July 23, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Quest Diagnostics Inc (NYSE:DGX) reported a strong r…
Cloud-based platform provides retrospective, program-level insight into kidney replacement therapy delivered in acute and hospital critical care settings Available within NxStage® System One™ with NxView™ 4.0, Fresenius Medical Care's FDA…
DaVita Inc. DVA, a well-known kidney care services provider, plays a central role in the dialysis ecosystem by providing comprehensive kidney care services for patients with chronic kidney disease (CKD) and end-stage kidney disease (ESKD).…
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. The European Medicines Agency committee has recommended revoking the EU marketing authorisation for…
Recommendation follows an Article 20 non-pharmacovigilance procedure Patients currently on TAVNEOS treatment should consult their treating physician ST. GALLEN, Switzerland, June 26, 2026 /PRNewswire/ -- Vifor Fresenius Medical Care Renal…
Investing.com -- Shares in Fresenius Medical Care (ETR:FMEG) fell about 5% Thursday after U.S. health regulator CMS proposed a smaller-than-expected increase to dialysis reimbursement rates and moved to bundle a key drug category into its…
Change on the Management Board Following the Scheduled end of Stefan Heidenreich's Term of Office DUDERSTADT, GERMANY - June 24, 2026 (NEWMEDIAWIRE) - Ottobock SE & Co. KGaA, the listed global MedTech company, has appointed Dr. Katarzyna M…
Kidney care continues to evolve as healthcare providers focus on improving outcomes for patients with chronic kidney disease (CKD) and end-stage kidney disease, with DaVita Inc. DVA and Fresenius Medical Care AG FMS representing two leadin…
Interwell achieved top quality scores and sustained savings growth over the first three years of the Kidney Care Choices Model BAD HOMBURG, Germany, June 10, 2026 /PRNewswire/ -- Interwell Health, the value-based care operating segment of…
Fresenius Medical Care FMS sits at the center of a dialysis market where patient growth is steadily pushing on capacity, labor, and cost structures. That backdrop makes modality and technology choices more than a clinical conversation. The…
Fresenius Medical Care AG & Co. FMS recently announced the global launch of kinexus, a digital platform to support home dialysis programs and enhance connected, patient-focused care. The platform integrates remote therapy monitoring, presc…
DaVita Inc. DVA is a key player in the dialysis space, providing comprehensive kidney care services to patients with chronic kidney disease (CKD) and end-stage kidney disease (ESKD). The company’s core business centers on delivering dialys…
DaVita Inc.’s DVA investors have been experiencing some short-term gains from the stock lately. Shares of the Denver, CO-based provider of dialysis services in the United States to patients suffering from chronic kidney failure gained 21.4…
Global launch of a single, integrated digital platform connecting remote therapy monitoring and operational workflows for home dialysis programs Designed to simplify care processes for healthcare teams and their patients to support high-qu…
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Fresenius Medical Care stock moves against mixed return backdrop Fresenius Medical Care (XTRA:FME…
BAD HOMBURG, Germany, May 28, 2026 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, today announced the launch of the first tranche of its new share bu…
Hemodiafiltration (HDF) research reinforces Fresenius Medical Care's continued leadership in advancing evidence-based dialysis care and treatment personalization New research focuses on applying real-world evidence, patient-centered outcom…
Total volume of the share buyback is around EUR 1 billion over 12 months Share buyback expected to begin in the near future BAD HOMBURG, Germany, May 26, 2026 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of pr…